TuBerculosis Vaccine Initiative
The TuBerculosis Vaccine Initiative (TBVI) is a Research and Innovation partnership that works to discover and develop new, safe and effective TB vaccines that are accessible and affordable for all people.
A non-profit foundation, TBVI creates an enabling environment for TB vaccine research and innovation (R&I) and product development. TBVI and its R&D partners develop and move the most promising TB vaccine and biomarker candidates through the pipeline. To continue to innovate and diversify the pipeline and TB vaccine platforms, TBVI supports collaborative research and innovation by its R&D partners. TBVI adds value through providing services of technical advice for product development; project identification, development and management; and resource mobilisation. TBVI works through the Global TB Vaccine Partnership (GTBVP) with global stakeholders to strengthen Global and European cooperation and coordination and identify and address gaps to move the field forward.